抗接触素相关蛋白的临床,电生理学和病理学特征 1 自身免疫性节节病症
Takumi Tashiro1, Hidenori Ogata1, Yuki Fukami2
1Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Neurology
|October 6, 2025
概括
在自身免疫结节病 (ANs) 中,抗接触素相关蛋白1 (Caspr1) 抗体与较早发病和明显的临床特征有关. 抗体标位可以作为监测Caspr1 AN.的疾病活动的生物标志物.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 自身免疫结节病 (ANs) 是一组罕见的神经系统疾病.
- 抗接触素相关蛋白1 (Caspr1) 抗体在ANs中的作用需要进一步澄清.
研究的目的:
- 在自身免疫结节病症中研究具有Caspr1抗体的患者的临床特征.
- 探索抗卡斯普1抗体的诊断和预后价值.
主要方法:
- 从慢性炎症性脱髓化多基原核神经病 (CIDP) 患者的血清样本进行了回顾性分析.
- 使用ELISA对抗Caspr1IgG的查,通过免疫组织化学和西部血栓检测得到证实.
- 收集临床,电生理学和病理学数据,包括炎症性神经病变的原因和治疗 (INCAT) 评分和血清神经丝光链 (NfL) 水平.
主要成果:
- 确定了19名患有抗卡斯普1IgG的患者,主要是IgG4亚类 (17/19).
- 患有IgG4 Caspr1 AN的患者在发病时呈现较大的年龄,男性占主导地位,四肢虚弱,步态障碍,感觉性缺氧和CSF蛋白质升高.
- 神经传导研究揭示了脱髓化特征,而外围神经活检显示了轴质脱落. IgG4 Caspr1 AN患者对IVIg反应不佳,需要联合免疫疗法. 血清NfL水平与INCAT分数相关.
结论:
- IgG4 Caspr1 AN表现出明显的临床表型,类似于其他结节病,但在发病时年龄较大.
- 反Caspr1抗体标位的变化可以作为监测Caspr1中疾病活性的潜在生物标志物.
相关概念视频
Myocarditis II: Clinical Features and Diagnostic Tests
265
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
265
Myocarditis I: Introduction
369
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
369
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.8K
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
Notch Signaling Pathway
6.4K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.4K


